Advertisement

Topics

Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug

09:17 EDT 12 Apr 2018 | Speciality Pharma Journal

NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Wilson Therapeutics AB (publ) announced today that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer, through a wholly-owned subsidiary. Wilson Therapeutics is a biopharmaceutical company, based in …

Original Article: Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug

NEXT ARTICLE

More From BioPortfolio on "Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...